The UK’s top health adviser during the Covid-19 pandemic, who sanctioned the purchase of the mRNA vaccines, has taken a top job with the drug’s manufacturer.
Will Ware has become the senior vice-president of global health policy at BioNTech, the manufacturer of the mRNA vaccine that is marketed by Pfizer.
Under Ware’s guidance, the UK purchased more mRNA vaccines than any other type. Pfizer and BioNTech made a hefty profit from the vaccine: it was selling each dose to the UK government for up to £22—but was costing the company just £5 per dose to manufacture. The companies’ joint profits from the UK alone are estimated to be around £2bn, and worldwide income for 2022 and this year is anticipated to be in the region of £36bn.
Ware left his health advisory job when Prime Minister Boris Johnson was deposed last year.